News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Drugmakers: Moratorium On Advertising New Drugs
June 20, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
June 16, 2008 - Pharmalot -- Responding to pressure from Congress, Merck, Schering-Plough, Johnson & Johnson and Pfizer agreed to a six-month moratorium on DTC ads for new drugs and will limit how docs are used in their ads.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Johnson & Johnson Family of Companies
Merck & Co.
Pfizer
MORE ON THIS TOPIC
Manufacturing
FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain
January 22, 2026
·
2 min read
·
Nick Paul Taylor
Pain
Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase III for Non-Opioid Pill
January 22, 2026
·
2 min read
·
Tristan Manalac
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
January 21, 2026
·
1 min read
·
Heather McKenzie
Manufacturing
CDMOs Pin Hopes for Accelerating Uptake at New US Sites on FDA’s PreCheck Program
January 20, 2026
·
4 min read
·
Nick Paul Taylor
